Melatonin

Lore & Background

In vertebrates, melatonin's functions extend to synchronizing sleep-wake cycles, encompassing sleep-wake timing and blood pressure regulation, as well as controlling seasonal rhythmicity, including reproduction, fattening, molting, and hibernation. Its effects are mediated through the activation of melatonin receptors and its role as an antioxidant. In plants and bacteria, it serves as a defense mechanism against oxidative stress, indicating its evolutionary significance. The pineal gland is the primary source of circulating melatonin in vertebrates, though melatonin is also produced locally in other tissues.

Reader's Guide

Melatonin is significant as a hormone that regulates circadian rhythms and as an antioxidant. In humans, it is used medically for sleep-related problems, such as prolonged-release melatonin (Circadin) approved in several countries for short-term treatment of insomnia in people aged 55 years or older. Numerous studies suggest that disruption of melatonin production may underlie the association between light exposure before and during sleep and impaired sleep quality, potentially affecting cognitive, emotional, cardiovascular, and metabolic functions. Melatonin acts as a full agonist of two melatonin receptors, MT1 and MT2, which are G-protein coupled receptors. In vitro, it functions as a high-capacity antioxidant within mitochondria, directly neutralizing free radicals and promoting the gene expression of antioxidant enzymes. Its biosynthesis in animals begins with L-tryptophan, proceeding through 5-hydroxytryptophan, serotonin, and N-acetylserotonin to produce melatonin. The compound's presence in mitochondria and chloroplasts suggests an evolutionary significance in cellular energy metabolism and defense against oxidative stress.

Did You Know?

• In humans, melatonin production diminishes as a person ages.
• Comparative antioxidant efficacy of melatonin versus vitamin E depends on assay conditions.
• The pineal gland is the primary source of circulating melatonin in vertebrates.

Origins and Evolutionary Depth

Lerner and his research team isolated a remarkable substance from the pineal glands of cattle. Their initial observation was striking: this compound could trigger skin lightening in common frogs, a finding that eventually led to its identification as a hormone released by the brain during nighttime hours. What makes melatonin's story particularly compelling is how far back its biological role stretches. Far from being a uniquely vertebrate innovation, this indoleamine is produced across a vast spectrum of life, from bacteria to eukaryotes. In plants and microbes, it functions primarily as a shield against oxidative stress, suggesting that its fundamental purpose predates the emergence of complex nervous systems. Mitochondria, the energy-producing organelles present in nearly all eukaryotic cells, serve as the principal site of melatonin synthesis. This mitochondrial connection underscores what researchers describe as the compound's ancient origins, pointing to a time when the earliest cells needed protection from reactive oxygen species. Melatonin, in this light, is not merely a sleep hormone but a deeply conserved molecular guardian woven into the fabric of cellular life.

Circadian Mastery Across the Human Lifespan

In vertebrates, melatonin operates as a master clock signal, orchestrating not only the timing of sleep and wakefulness but also blood pressure fluctuations and the broader seasonal rhythms that govern reproduction, fat storage, molting, and hibernation. In humans, the trajectory of melatonin production follows a distinct developmental arc. Regular, predictable levels first emerge around the third month of infancy, with peak concentrations typically occurring between midnight and eight in the morning. As individuals age, the body's capacity to synthesize this hormone gradually declines. A particularly notable shift occurs during adolescence, when the timing of melatonin secretion drifts later, pushing sleep and wake times backward and elevating the risk of delayed sleep phase disorder. In healthy adults, roughly thirty micrograms are produced daily, with nearly eighty percent of that output concentrated in the nighttime hours. Research further indicates that artificial light exposure before or during sleep can suppress melatonin production, a disruption that may ripple outward to impair cognitive performance, emotional stability, cardiovascular health, and metabolic function.

Cellular Defense and the Antioxidant Arsenal

Within mitochondria, melatonin acts as a high-capacity free radical scavenger, directly neutralizing reactive oxygen species such as hydroxyl radicals, superoxide anions, and reactive nitrogen species including nitric oxide. Beyond this immediate chemical neutralization, melatonin triggers a second, more sustained defense: through its binding to specific receptors, it activates signal transduction pathways that upregulate the expression of critical antioxidant enzymes, including superoxide dismutase, glutathione peroxidase, glutathione reductase, and catalase. In plant systems, melatonin works synergistically with other antioxidants, and studies have shown it to be twice as effective as vitamin E at scavenging peroxyl radicals. The concentration of melatonin within the mitochondrial matrix far exceeds its levels in blood plasma, highlighting its central role in preserving mitochondrial integrity. Moreover, the metabolites generated when melatonin interacts with free radicals—cyclic 3-hydroxymelatonin, AFMK, and AMK—themselves participate in further redox reactions, extending the molecule's protective reach well beyond its initial encounter with oxidative stress.

Clinical Applications and Broader Physiological Reach

Beyond its endogenous roles, melatonin has found a place in clinical medicine, primarily as a treatment for sleep-related conditions. Prolonged-release formulations, such as Circadin, have received regulatory approval in several countries for the short-term management of insomnia in adults aged fifty-five and older, and the compound is also employed in addressing various circadian rhythm sleep disorders. At the molecular level, melatonin is believed to act as a full agonist at two receptor subtypes: MT1, which exhibits picomolar binding affinity, and MT2, with nanomolar affinity. Both belong to the Gi/o alpha subunit family of G-protein coupled receptors. The physiological reach of melatonin extends well beyond sleep. Preclinical evidence suggests it may exert anti-inflammatory effects and augment cytokine production while promoting T-cell expansion, potentially offering benefits against acquired immunodeficiencies. Its interaction with the immune system, however, remains incompletely characterized, with most available data drawn from small-scale preliminary studies. Additionally, melatonin appears to influence weight regulation through an inhibitory effect on leptin, the hormone that signals long-term energy status. Collectively, these findings paint melatonin as a multifaceted regulator whose influence spans sleep, immunity, and metabolic balance.